Paragon 28 to Present at Upcoming Investor Conferences

Rhea-AI Summary

Paragon 28, a medical device company focused on the foot and ankle orthopedic market, announced that Chairman and CEO Albert DaCosta and CFO Steve Deitsch will present at two investor conferences. The first event is the CG 2023 Musculoskeletal Conference on March 7, 2023, at 4:00 PM ET, and the second is the 22nd Annual Needham Virtual Healthcare Conference on April 19, 2023, at 11:00 AM ET. Live and archived webcasts will be available on the company’s website. Paragon 28 aims to improve patient outcomes through innovative orthopedic solutions for various foot and ankle conditions.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting in fireside chats at two upcoming investor conferences. Paragon 28 will participate in the CG 2023 Musculoskeletal Conference on March 7^th, 2023, and the 22^nd Annual Needham Virtual Healthcare Conference on April 19^th, 2023.

Event: CG 2023 Musculoskeletal Conference
Date: Tuesday, March 7, 2023
Time: 4:00pm ET / 1:00pm PT

Event: 22^nd Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 19, 2023
Time: 11:00am ET / 8:00am PT

Live and archived webcasts of the fireside chats will be available on the “Investors” section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230301006006/en/

Investor Contact

Matthew Brinckman

Senior Vice President, Strategy and Investor Relations

Phone: (741) 336-0435

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

FAQ

What is the date of the CG 2023 Musculoskeletal Conference where Paragon 28 will present?

Paragon 28 will present at the CG 2023 Musculoskeletal Conference on March 7, 2023.

What time will the Needham Virtual Healthcare Conference take place for Paragon 28?

The Needham Virtual Healthcare Conference will take place at 11:00 AM ET on April 19, 2023.

Who will represent Paragon 28 at the upcoming investor conferences?

Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will represent Paragon 28.

Where can I find the webcasts of Paragon 28’s presentations?

Live and archived webcasts will be available in the 'Investors' section of Paragon 28's website.

What is the stock symbol for Paragon 28?

The stock symbol for Paragon 28 is FNA.